Oncology Data Advisor cover art

All Episodes

Oncology Data Advisor — 444 episodes

#
Title
1

One Size Fits One: Personalizing Cancer Prevention Through AI-Enhanced Imaging

2

Precision Decisions in NDMM: Live Virtual Rounds Preview

3

Multidisciplinary Realities: Tumor Board vs Tuesday Afternoon

4

The Real World vs The Trial Patient: Bridging the Gap

5

AI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application

6

Solving the PFIC Mystery: Genetic Testing and Diagnosis in Adults

7

HelioLiver: Expanding Early Detection of Hepatocellular Carcinoma With AI

8

New Frontiers in Esophagogastric Cancer with Dr. Yelena Janjigian

9

HER2-Mutant NSCLC Update: Expanded Approval of Zongertinib

10

Choosing Not to Treat: How Do You Know When the Best Treatment Is No Treatment?

11

Additional Advances in Systemic Mastocytosis Research and Clinical Trials With Mariana Castells, MD, PhD

12

The Future of Hemophilia: New Data, New Guidance, New Outcomes with Robert F. Sidonio, Jr., MD, MSc

13

iNav: How AI-Driven Navigation Is Accelerating Pancreatic Cancer Care With Daniel King, MD, PhD, and Waqas Haque, MD, MPH

14

Closing the Gaps in NET Diagnosis and Treatment: A Conversation With Aman Chauhan, MD

15

Molecular Testing Chaos: Are We Over Testing, Under Testing, or Testing the Wrong Things at the Wrong Time?

16

If a Patient Can’t Afford to Fill the Prescription, Is It Really a Treatment Option?

17

Living with Psoriatic Arthritis: A Patient’s Perspective on Biologics, Weight Loss & Early Diagnosis

18

Additional Advances in Melanoma Research and Clinical Trials With Michael A. Davies, MD, PhD + Module 2

19

Additional Advances in Melanoma Research and Clinical Trials With Michael A. Davies, MD, PhD + Module 1

20

Navigating HER2-Mutant NSCLC Pathology and Management: A Webinar Preview With Helena A. Yu, MD, and Maria Arcila, MD

21

Discovering Systemic Mastocytosis in Practice: A Webinar Preview With Lauren M. Madigan, MD

22

Improving Early and Equitable Lung Cancer Detection With Sybil: Mary Pasquinelli, DNP, FNP-BC, CTTS, and Waqas Haque

23

Additional Advances in Systemic Mastocytosis With Mariana Castells, MD, PhD + Module 2

24

Additional Advances in Systemic Mastocytosis Research and Clinical Trials With Mariana Castells, MD, PhD + Module 1

25

Charting New Paths in Oncology Informatics With Travis Osterman, DO, and Waqas Haque, MD, MPH

26

Optimizing CLL Care: Pharmacist-Led Strategies for Treatment Selection and Toxicity Management

27

Clinical Challenges in Extrapulmonary NEC: Expert Insights on Diagnosis, Treatment, and Emerging Targets

28

From Abstracts to Action: How ASCOmind Streamlines Oncology Insights With Xiaoyan Wang, PhD; William Oh, MD; and Waqas Haque, MD, MPH

29

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care Module 2

30

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1

31

Additional Advances in Genetic Counseling and Testing in Cancer Care With Filipa Lynce, MD, and Catherine Skefos, MA, MS, CGC

32

Additional Advances in HER2-Mutated NSCLC With Julia Kathleen Rotow, MD + Activity Module 2

33

Additional Advances in HER2-Mutated NSCLC With Julia Kathleen Rotow, MD + Activity Module 1

34

Unmasking Hereditary ATTR-CM: A Webinar Preview With Mathew Maurer, MD

35

Multicancer Early Detection: A Fellow’s Perspective With Waqas Haque, MD, MPH

36

Additional Insights in Dedifferentiated Liposarcoma With Richard F. Riedel, MD, and Candace L. Haddox, MD

37

Exploring the Evolution of Neuroendocrine Tumor Diagnostics and Therapeutics: A Webinar Preview With Aman Chauhan, MD

38

A Return on Humanity: How the American Cancer Society Uses AI to Improve Patient Care

39

Challenges and Innovations in Biliary Tract Cancer: A Multidisciplinary Task Force Perspective

40

Building Effective AI Foundation Models at Standard Model Biomedicine With Kevin Brown and Waqas Haque, MD, MPH

41

Reimagining Oncology Nursing Through AI Innovations: Waqas Haque, Kathleen McGrow, Sangeeta Agarawal, Marc Perkins-Carrillo

42

Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes Module 2

43

Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes - Module 1

44

Harnessing AI for Early Lung Cancer Detection: Qure.ai’s Innovations and Impact

45

Additional Advances in Relapsed/Refractory Multiple Myeloma Research and Clinical Trials With Rahul Banerjee, MD, FACP

46

Additional Advances in Stem Cell Mobilization Research and Clinical Trials in Multiple Myeloma With Hamza Hashmi, MD

47

Additional Advances in Renal Cell Carcinoma Research and Clinical Trials With Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC

48

From Glass Slides to AI: How Digital Pathology and MRD Testing Are Transforming Cancer Care With Osama Khan, MD, and Waqas Haque, MD, MPH

49

How AI Is Revolutionizing Precision Oncology With Ian Maurer and Jasmin Hundal, MD, MS, MPH

50

Mendel AI: Enhancing Clinical Data Processing for Empowered Clinical Decision Making With Kristin Maloney, MS, BSN, RN, OCN®, and Waqas Haque, MD, MPH

51

Ontada, Microsoft, and Azure AI: Collaborating to Transform Real-Word Data Processing in Oncology

52

Zanidatamab: A New Frontier in Treating HER2-Positive Biliary Tract Cancer With James Harding, MD

53

Lung Cancer Awareness Month: Treatment Updates in 2024

54

Clinic Conversation of the Week: How to Talk to Patients About the BENEFIT Trial in Multiple Myeloma

55

Artera: Personalizing Treatment Decisions in Prostate Cancer and Beyond With Waqas Haque, MD, MPH, and Trevor Royce, MD, MS, MPH, FASCO

56

Exclusive Sneak Peek: Unlocking What's Next in Genetic Counseling and Cancer Care!

57

Revolutionizing Cancer Diagnostics Through AI-Powered Analysis: CorePath

58

Additional Advances in Head and Neck Squamous Cell Carcinoma With Deborah Wong, MD, PhD

59

Navigating Patients Through the CKD Journey with Value-Based Care Plus CPE-Accredited Podcast

60

Additional Advances in Immune-Related Adverse Events Research and Trials: Beth Sandy, MSN, CRNP

61

iCAD: Creating a World Where Cancer Can’t Hide With Waqas Haque, MD, MPH, and Dana Brown

62

Palliative Care and Oncology: Partners in Patient Care With Richa Thakur, MD, and Janet Abrahm, MD

63

The Digital Fingerprint: Accelerating Personalized Drug Discovery and Development at iLoF

64

Reimagining Surgery Through AI and Computer Vision Technology: Dr. Tamir Wolf and Dr. Waqas Haque

65

Investigating Axicabtagene Ciloleucel for R/R Central Nervous System Lymphoma: Lakshmi Nayak, MD

66

Combating Health Disparities Through More Equitable Screening: Chyke Doubeni, MD, MPH

67

Multicancer Early Detection - What's Your Opinion? with Chyke Doubeni, MD, MPH

68

The Latest Data on Zanidatamab for HER2-Positive Biliary Tract Cancer: Shubham Pant, MD

69

Biomarker Documentation in the Community Setting and Clinical Decision Support: Daniel Rubin, PharmD

70

Community Oncology Pharmacists - Their Crucial Role and Clinical Impact: Andrea Roman, PharmD, BCOP

71

Cancer and Careers - Empowering People with Cancer to Thrive in the Workplace: Rebecca Nellis, MPP

72

Exploring Association of FGFR3 Alterations in Urothelial Cancer: Arlene Siefker-Radtke, MD

73

Representing Symptom Research and Nursing at ASCO: Natalie Jackson-Carroll, PhD, APRN, FNP-C

74

Worth the Wait - Supporting Young Adult Cancer Survivors on the Path to Parenthood: Mike Scherer

75

Optimizing Sacituzumab Govitecan Tolerability in TNBC With Early Management: Antonio Llombart, MD

76

Understanding Lung Cancer Diagnostic Trends to Inform Therapeutic Development: Jess Paulus, SCd

77

Intuitively Designing Clinical Trials to Empower Patients: Ishwaria Subbiah, MD

78

Updated Results from the SPOTLIGHT and EV-302 Trials at ASCO: Ahsan Arozullah, MD, MPH

79

Improving Long-Term Survivorship Care in Head and Neck Cancer With Erica Fortune, PhD

80

Addressing Barriers to Transplantation Accessibility With Monzr Al Malki, MD, and Richa Thakur, MD

81

Qure.ai: Improving Early Lung Cancer Detection Through AI with Ranjana Devi and Waqas Haque, MD, MPH

82

A Sneak Peek Into Von Hippel-Lindau Disease Treatment Advances: Eric Jonasch, MD

83

Effective Care for Substance Use Disorders in Cancer, APN Perspective: Gretchen McNally, APRN-CRP

84

Exploring the Tumor Microenvironment of Invasive Lobular Carcinoma: Jason Mouabbi, MD

85

Advocates for Universal DPD/DPYD Testing: Karen Merritt and Dan Hertz, PharmD, PhD

86

Highlights of Brain Tumor and CNS Research at ASCO: Morana Vojnic, MD, MBA

87

Predicting Immunotherapy Benefit in Lung Cancer and Beyond: Ofer Sharon, MD

88

Developing a TNBC Polygenic Risk Score for Black Women: Holly Pederson, MD, and Elisha Hughes, PhD

89

Highlights of Sarcoma Research Presented at ASCO: Richard Riedel, MD

90

Analyzing Enzalutamide Patient-Reported Outcomes and QOL in the EMBARK Trial: Stephen Freedland, MD

91

Blue Faery - Improving Liver Cancer Care Through Research and Education: Andrea Wilson Woods

92

Count Me In - Partnering With Patients to Accelerate the Pace of Cancer Research: Melissa Mirick

93

An Innovative Wellness and Professional Development Curriculum for Fellows: Thejal Srikumar, MD

94

Implementing a Novel Research Methods Training Curriculum for Fellows: Noha Sharafeldin, MD, PhD, and Waqas Haque, MD

95

Understanding Cardiovascular Risks of BTK Inhibitors in Hematologic Malignancies: Muhammad Salman Faisal, MBBS

96

The Fellow on Call and Fellowship Research at ASCO: Ronak Mistry, DO, and Vivek Patel, MD

97

Assessing Risk of Myelosuppression With PARP Inhibitors in Prostate Cancer: Karan Jatwani, MBBS

98

Artful Oncology - A Psychosocial Oncology Curriculum for Heme/Onc Fellows: Jafar Al-Mondhiry, MD

99

The Sarcoma Foundation of America: Brandi Felser and Waqas Haque, MD, MPH

100

The Fellows Forum Live from ASCO 2024: Samuel Kareff, MD, Waqas Haque, MD, and Matthew Hadfield, DO

101

Piloting Palliative Care Education for Fellows: Jessica Bauman, MD

102

Representing Fellows in Evidence-Based Wellness Interventions: Andrew Hearn, MD, MSCI

103

Cold Agglutinin Disease: Answers to Frequently Asked Questions With Catherine Broome, MD

104

Early-Stage Non–Small Cell Lung Cancer: Answers to Frequently Asked Questions

105

Additional Advances in Triple-Negative Breast Cancer Research and Trials: Sara M. Tolaney, MD, MPH

106

A Precision Health Approach to Post-Treatment Comorbid Diabetes in Cancer With Marilyn Hammer

107

Igniting the Extraordinary Through AYA and LGBTQ+ Research at ONS With Lauren Ghazal

108

Starting the Conversation: End-of-Life Communication in Oncology Nursing With Stacey Simons

109

Climate Change and Healthcare: What We Can Do To Help - AnnMarie Walton, Ryne Wilson, Stacy Stanifer

110

Incorporating Patient-Reported Outcomes in Oncology Research: Elaine Novakovich and Theresa Yu

111

Food for Thought: Nutrition in Vulnerable Cancer Populations With Mariah Jackson and Caitlin Benda,

112

Highlights of ONS Congress 2024 With Maria Badillo

113

OurBrainBank: Creating Change in Glioblastoma Treatment With Kelli Duprey and David Robles

114

Supporting Nurses Returning to Work After Cancer Diagnosis With Kai-Lin You

115

Championing Policy Advocacy in Cancer: Carley VonHeeder and Gilanie De Castro

116

Providing Evidence to Support New Product Introductions in Nursing: Colleen O’Leary

117

“Speed Dating” - Bridging the Gap Between DNP and PhD Nurses: James Simmons and Cheryl Le Huquet

118

Welcoming the New Oncology Nursing Society President, Jessica MacIntyre

119

Bridging Nursing Learning Gaps Through an Advanced Practice Provider Fellowship: Amelia Cataldo

120

Launching the Genetic Cancer Prevention Clinic: Kathy Pratt and Megan Templo

121

The Future of Oncology Research - Cutting-Edge Approaches Using AI: Maxim Topaz

122

Discussing Cancer Fatalism and Risky Health Behaviors: Maryum Zaidi

123

Mitigating Financial Toxicity Experienced by Cancer Survivors: Dan Sherman

124

Smith Center for Healing and the Arts: Erin Price and Laura Pole

125

Tackling Disparities Experienced by LGBTQ+ Cancer Survivors: Kelly Tan

126

Additional Advances in Multiple Myeloma Research and Clinical Trials With Rahul Banerjee, MD, FACP

127

Recurrent/Metastatic HNSCC: Answers To Frequently Asked Questions With Assuntina G. Sacco, MD

128

Acid Sphingomyelinase Deficiency: Answers To Frequently Asked Questions With Neal Weinreb, MD

129

Every Cure: Unlocking Drug Potential With Artificial Intelligence With Waqas Haque and Tracey Sikora

130

Acute Myeloid Leukemia (AML) Awareness Day: Evolving Treatment Directions

131

Testicular Cancer Awareness Month: Improving Detection, Management, and Survivorship

132

Celebrating Head and Neck Cancer Awareness Month

133

Esophageal Cancer Awareness Month: Treatment Advances and Tools for Maximizing Tolerability

134

Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Updates on LINKER-MM1 From AACR 2024

135

Improving Breast Cancer Surgical Outcomes With Lymphovenous Bypass

136

AYA Cancer Awareness Week 2024

137

Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research: Christopher Lieu, MD

138

National Doctor’s Day With Samuel Kareff, MD, MPH, and Matthew Hadfield, DO

139

Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes

140

Fighting Hereditary Colorectal Cancer With Genetic Counseling: Catherine Skefos and Julie Moskowitz

141

International Women’s Day: Perspectives in Medicine, Nursing, and Fellowship

142

Additional Advances in aTTP Research and Clinical Trials With Spero Cataland, MD

143

Kidney Cancer Awareness Month: Spotlight on Genetic Counseling

144

Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD

145

Multiple Myeloma Awareness Month 2024: What Patients Need to Know

146

Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD

147

Introduction to Genetic Counseling With Hiam Abdel-Salam, MS, CGC, and Catherine Skefos, MA, MS, CGC

148

Thirty Years in the Making: The Approval of Lifileucel for Metastatic Melanoma

149

International Women’s Day With Alankrita Taneja, Maria Badillo, Ulka Vaishampayan, and Morana Vojnic

150

Discovering Research Advances in Mesothelioma: Samuel Kareff, MD, MPH, and Estela Rodriguez, MD, MPH

151

Rare Disease Day 2024 With Rahul Banerjee, Matthew Hadfield, Joseph Kalis, and Nagashree Seetharamu

152

Exploring the Intersection of Emergency Medicine and Oncology With Joseph Oropeza and Joseph Kalis

153

Colorectal Cancer Awareness Month With Allison Rosen, MS, and Matthew Hadfield, DO

154

Expanding Clinical Trial Access With Decentralization and Technology: Waqas Haque and Shaalan Beg

155

National Donor Day: How To Be the Match With Richa Thakur, MD, and Will Smith

156

Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forward

157

National Cancer Prevention Month: Rising Trends and How to Combat Them

158

Breaking Developments in Neuroendocrine Tumor Research: Dr. Samuel Kareff and Dr. Aman Chauhan

159

World Cancer Day 2024 with Oncology Data Advisor

160

Gallbladder and Bile Duct Cancer Awareness Month: Improving Screening and Treatment Options

161

National Cancer Prevention Month With Stephen Freedland and William Aronson

162

Streamlining the Pathology Workflow Through AI: Waqas Haque and Leif Honda of TriMetis

163

Capivasertib for PIK3CA/AKT1/PTEN–Altered Breast Cancer With Jason Mouabbi, MD, and Carlos Doti, MD

164

Patterns of Care With BTK Inhibitors for CLL/SLL in the Community Setting: David Andorsky, MD

165

Investigating Hypomethylating Agents for Myelodysplastic Syndromes With Amer Zeidan

166

Epcoritamab for FL: Matt Hadfield, Alankrita Taneja, Tahi Ahmadi, Jacqueline Nielsen

167

Managing Acute Leukemias and Lymphomas When Patients Stay Local: Dipti Patel-Donnelly, MD

168

Real-World Outcomes of Brexuctabtagene Autoleucel for B-Cell ALL: Evandro Bezerra, MD

169

Nurse Navigation to Address Socioeconomic Disparities in ALL Treatment: Greg Knight, MD

170

Exploring Revumenib for KMT2-Rearranged Acute Leukemias in the AUGMENT Trial: Ibrahim Aldoss, MD

171

Utilizing ctDNA to Assess Survival With Odronextamab for FL and DLBCL: Jon Arnason, MD

172

Investigating Talquetamab + Pomalidomide in the MonumenTAL-2 Study: Jeffrey Matous, MD

173

Improving QOL in Multiple Myeloma With Bortezomib Dose Reduction: Rahul Banerjee and Gurbakhash Kaur

174

Guiding Dietary Choices During Multiple Myeloma Treatment: Richa Parikh, MD

175

Improving End-of-Life Care for Patients With AML Receiving Non-Curative Therapy: Richa Thakur, MD

176

Coping With Psychological Distress Prior to Hematopoietic Cell Transplantation: Richard Newcomb, MD

177

Investigating Odronextamab for R/R FL and DLBCL in the ELM-2 Study: Sabarish Ayyappan, MD

178

Exploring Acalabrutinib ± Obinutuzumab for CLL in the ELEVATE-TN Study: Jeff Sharman, MD

179

Highlights of Multiple Myeloma Research Presented at ASH 2023: Urvi Shah, MD

180

Predicting Immune-Related Adverse Events Through Machine Learning With Dr. Ofer Sharon of OncoHost

181

Racial and Socioeconomic Disparities in the CLL Community Oncology Setting: Ira Zackon, MD

182

Response Patterns of Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Hans Lee, MD

183

Real-World Outcomes of Brexucabtagene Autoleucel for Mantle Cell Lymphoma: Swetha Kambhampati, MD

184

Investigating Therapies Targeting Cardiovascular Health in MDS: Diego Adrianzen Herrera, MD

185

Improving Diversity in Multiple Myeloma Clinical Trials: Craig Cole, MD

186

Empowering Patients Through Shared Decision Making in Myelodysplastic Syndromes: Claire Saxton

187

Mitigating the Effects of Neighborhood Disadvantage in Acute Myeloid Leukemia: Brittany Ragon, MD

188

CLL Society: Paving the Way For CLL Patients and Survivors With Brian Koffman, MD

189

A Mobile App to Address Sexual Dysfunction in HSCT Survivors: Areej El-Jawahri, MD

190

Exploring Results of the IsKia Trial in Newly Diagnosed Multiple Myeloma: Annemiek Broijl, MD

191

Highlights From the 2023 San Antonio Breast Cancer Symposium With Jason Mouabbi, MD

192

Reducing Stigmatizing Language in the EMR for More Equitable Care: Alex Boucher, MD

193

Expanding Access to Brexucabtagene Autoleucel for Mantle Cell Lymphoma: Andre Goy, MD

194

Addressing Ethical Concerns Around Artificial Intelligence in Cancer Care: Andrew Hantel, MD

195

Lowering Talquetamab Dosing Intensity to Improve Tolerability: Ajai Chari, MD

196

Advancing Inclusion for Blood Donation Systems for Marginalized Groups: Warren Fingrut, MD

197

Investigating CD19-Targeted CAR T Cells for Autoimmune Diseases: Fabian Mueller, MD

198

Evaluating Outpatient Teclistamab Administration in Multiple Myeloma: Robert Rifkin, MD

199

Financial Hardship Experienced During Transplant in Myelodysplastic Syndromes: Christopher Su, MD

200

Maintaining Functioning and QOL With Odronextamab for Follicular Lymphoma: Benoit Tessoulin, MD

201

Harnessing Machine Learning for MCL Risk Prognostication With Adrian Mosquera, MD, PhD

202

New Lung Cancer Screening Guidelines With Brian Whang

203

TALAPRO-2 (Talazoparib + Enzalutamide) in Prostate Cancer: Stephen Freedland and Neeraj Agarwal

204

Implementing Hepatic Artery Infusion Pump Programs With Sepideh Gholami, MD, MAS, FACS, FSSO

205

Enzalutamide Approved for Nonmetastatic CSPC With Biochemical Recurrence: Stephen Freedland, MD

206

Additional Advances in Advanced Prostate Cancer With Tanya Dorff, MD

207

Pancreatic Cancer Awareness Month: Improving Early Detection With Joseph Kalis, PharmD, BCOP

208

Lung Cancer Awareness Month: Global Perspectives With MedNews Week and Oncology Data Advisor

209

National Family Caregivers Month With Megan-Claire Chase

210

Great American Smokeout: The Link Between Smoking and Prostate Cancer With Stephen Freedland, MD

211

National Family Caregivers Month: The Nurse’s Perspective With Maria Badillo, MSN, RN, OCN®, CCRP

212

Venetoclax for Multiple Myeloma in the Post-CANOVA Era: Rahul Banerjee, MD, FACP, and Andrew Yee, MD

213

Lung Cancer Awareness Month With Waqas Haque, Samuel Kareff, & Matthew Hadfield

214

Updates on Bispecific Antibodies in Multiple Myeloma From IMS 2023: Rahul Banerjee and Shonali Midha

215

The Importance of Exercise for Cancer Survivorship With Nagashree Seetharamu

216

Creating Educational Opportunities During Fellowship and Beyond With Sam Kareff and Matt Hadfield

217

Real-World Use Patterns, Effectiveness, & Tolerability of Sacituzumab Govitecan for TNBC

218

Additional Advances in Newly Diagnosed Multiple Myeloma: Interview + Free CPE Podcast

219

Reframing the Conversation in Metastatic Breast Cancer With Janie Metsker, RN, BSN, CN-BN

220

Tisotumab Vedotin for Metastatic Cervical Cancer: Results From ESMO 2023 With Brian Slomovitz, MD

221

World Cancer Research Day With Samuel Kareff, Maria Badillo, Matthew Hadfield, and Alankrita Taneja

222

Additional Advances in SCLC Radiotherapy With Henry Park, MD, MPH + Free CME/NCPD/CPE Podcast

223

Additional Advances in Small Cell Lung Cancer Radiotherapy With Henry Park, MD, MPH

224

Exploring Opportunities During Hematology/Oncology Fellowship With Matthew Hadfield and Richa Thakur

225

Twice Weekly, Biweekly, Somewhere in Between? Dosing in Myeloma: Rahul Banerjee and Gurbakhash Kaur

226

Enfortumab Vedotin Plus Pembrolizumab: Results of the EV-302 Trial With Thomas Powles

227

The Rise of Immunotherapy: Considerations to Ensure Optimal Management With Matthew Hadfield, DO

228

Self-Management Strategies for Peripheral Neuropathy With Connie Visovsky, PhD, RN, ACNP, FAAN

229

Finding Your Why: Reflecting on the Passion Behind Oncology Nursing With Lauren Ghazal, PhD, FNP-BC

230

Breast Cancer Awareness Month: Debunking Breast Cancer Myths With Jason Mouabbi, MD

231

Pink Fund: Financial Assistance During Breast Cancer Treatment With Founder Molly MacDonald

232

The Power of Interdisciplinary Oncology Collaboration: Oncology Data Advisor and MedNews Week

233

Embracing Compassion in Health Care: The Power of Being Present With Marcus Engel, MS, CXCP, CSP

234

Take a Loved One to the Doctor Day With Beth Sandy, MSN, CRNP

235

Linvoseltamab for Multiple Myeloma: Results from IMS 2023 With Madhav Dhodapkar, MD

236

Melphalan for Liver-Directed Treatment of Uveal Melanoma With Richard Carvajal, MD

237

World Cancer Research Day: How to Get Involved in Research With Waqas Haque, MD, MPH

238

Pain Awareness Month With NIda Khan, MD, and Joseph Kalis, PharmD, BCOP

239

Prostate Cancer Awareness Month With Ulka Vaishampayan, MD

240

Raising Awareness of Prostate Cancer in Transgender Women: Farnoosh Nik-Ahd and Stephen Freedland

241

Understanding the Tumor Microenvironment for Oncology Drug Development With Jesus Garcia, PhD

242

Appendix Cancer Awareness Month With Thomas Abrams, MD

243

National Immunization Awareness Month: Richa Thakur and Waqas Haque

244

Investigating Epcoritamab for Follicular Lymphoma and Beyond With Reid Merryman, MD

245

Harnessing Precision Medicine in Oncology With Ofer Sharon, MD

246

Thinking Outside the Box: Integrating Wellness and Natural Medicine Into Pharmacy

247

Taking the Stage for Patient Advocacy With Megan-Claire Chase

248

Hematology/Oncology Trainee Experiences During COVID-19: Samuel Kareff and Ana Velazquez Mañana

249

Expert Perspectives in the Management of Triple-Negative Breast Cancer:Webinar Preview, Sara Tolaney

250

Navigating the Fellowship Experience by Creating Opportunities in Oncology With Waqas Haque

251

Trailblazing Oncology/Palliative Care Fellowship and Finding Your Niche: Richa Thakur and Nida Khan

252

Understanding and Improving Quality of Life for Cancer Patients Through Nursing Research

253

Coping With the Uncertainty of Indolent Non-Hodgkin Lymphoma With Richard Newcomb, MD

254

Improving Outcomes for IDH1/2-Mutant Glioma in the INDIGO Study With Timothy Cloughesy, MD

255

Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma With Thomas Hutson, MD

256

Leveraging Community-Academic Partnerships for Latinx AYA Cancer Survivors With Stephanie Smith, MD

257

Results of the HERIZON-BTC-01 Trial of Zanidatamab in Biliary Tract Cancers With Shubham Pant, MD

258

Partnering With Patients Through Advocacy With Allison Rosen

259

Expanding Global Health Education Through Video and Social Media With Yan Leyfman, MD

260

Coaching Cancer Survivors Through Digital Health: Robin Lally, PhD, and Marilyn Hammer, PhD

261

mCSPC: Real World Characteristics and Treatment by Disease Volume With Stephen Freedland, MD

262

Exciting New Directions for Oncology Data Advisor: Live From ASCO 2023 With Dr.Thomas Abrams

263

Social Media’s Effect on Informed Decision Making in Cancer: Nina Morena and Ari Meguerditchian

264

Exploring the Approval of Epcoritamab for Diffuse Large B-Cell Lymphoma With Reid Merryman, MD

265

Reducing Drug Waste Through Dose Rounding of Bevacizumab With Puneeth Indurlal, MD

266

Exploring the ARTISTRY-7 Trial of Nemvaleukin Alfa in Ovarian Cancer With Noelle Cloven, MD

267

Impact of Social Determinants of Health on TNBC Treatment With Nicholas Robert, MD

268

Accelerated Brain Age in Survivors of Childhood Cancer With Nicholas Phillips, MD

269

Supporting Patients Through Employment Disruptions During Cancer With Michael Halpern, MD

270

Molecular Analyses of Sacituzumab Govitecan in Urothelial Carcinoma With Manoj Bupathi, MD

271

Understanding Sexual Orientation and Gender Identity Data Collection: Mandi Pratt-Chapman, PhD

272

Payment Reform Through the Enhancing Oncology Model With Lalan Wilfong, MD

273

Spotlighting Zolbetuximab for Gastric/Gastroesophageal Junction Adenocarcinoma: Kohei Shitara, MD

274

Groundbreaking Results of Mirvetuximab Soravtansine for Ovarian Cancer With Kathleen Moore, MD

275

See, Hear, Feel: Cognitive Psychology and Emotional Intelligence in Medicine With Christine Ko, MD

276

Exploring Primary Overall Survival Results of Axicabtagene Ciloleucel in ZUMA-7: Jason Westin, MD

277

Finding Real-World Response End Points in NSCLC Data Sets With Janet Espirito, PharmD

278

Trastuzumab Deruxtecan Safety on HER2 Expressing Solid Tumors With Funda Meric-Bernstam, MD

279

The Value of Integrated Palliative Care Training During Fellowship With Richa Thakur, MD

280

HemePath Hub, a Unique Learning Opportunity: Dr. Aamir Ehsan and Dr. Bridget Herschap

281

Social Determinants of Health and Genetic Testing in Triple-Negative Breast Cancer: Barb Kunz, LCGC

282

Renal Cell Carcinoma Research and Shared Decision Making With Bradley McGregor, MD

283

Pickles Group: Supporting Kids Impacted by Parental Cancer With Cassy Horton

284

Improving Hereditary Cancer Genetic Testing for Black Individuals and Families: Darya Kizub, MD

285

Medical Cannabis Educational Training for Oncology Fellows With Deepa Rangacharia, MD

286

Reducing Cost of Cancer Care Through Novel Therapy Adjustment With Erica Feinberg, PharmD

287

Additional Advances in PI3K Inhibitor Research & Clinical Trials With Janie Metsker, RN, BSN, CN-BN

288

An Exclusive Interview With Joseph Kalis, PharmD, BCOP, and the Pharmacy Podcast Network

289

Creating Welcoming Spaces for LGBTQ+ Cancer Survivorship Care With Megan Mullins, MD, MPH

290

Getting to the Heart of Cardio-Oncology With Jessica Coviello, DNP, RN, ANP-BC

291

Faculty Interview & Free CME/NCPD Activity: Graft-Versus-Host Disease

292

Inspiring a Fulfilling Career in Nursing With Lauren Ghazal, PhD, FNP-BC

293

Validating Oncology Nursing Experience Through ONCC Certification: Tony Ellis, MSEd, CAE, ICE-CCP

294

Caring for Caregivers With Natalie McAndrew, PhD, RN, ACNS-BC, CCRN-K

295

Cancer Care Delivery Across Practice Settings: Michi Gray, RN, and Joscelyn Vanduren, ANP

296

Highlights of ONS Congress 2023 With Maria Badillo, MSN, RN, OCN, CCRP

297

Project Life and Cancer Survivorship With Lesley Glenn

298

Additional Advances in Castration-Resistant Prostate Cancer Research: Kathleen Burns, MSN, NP

299

Exploring Hot Topics in Radiation Oncology With John Hillson, RN, BSN, OCN

300

Staying Proactive in Management of Infusion-Related Reactions With Julianna Cebollero, PharmD, BCOP

301

The Unscripted Pharmacist With Lenora Casey, OCN, BSN-RN

302

What Are Ethical Dilemmas in Research Nursing, and How Do We Manage Them? With Doyle Bosque

303

Unleashing the Power of Therapy Dogs for Cancer Patients: Colleen Stoner and Diane Haley, LCSW

304

Reflecting on Body Image for Women With Head and Neck Cancer: Colette Baudoin, PhD, RN

305

Strengthening Nursing Sustainability: Amy Rettig, DNP, RN, APRN-BC

306

Exploring Virtual Reality for Patients With Brain Cancer: Amanda King, APNP-BC

307

Igniting a Passion for Oncology Nursing: Cure Extraordinary Healer Award® Winner Abbey Kaler, APRN

308

Staying Ahead of Hyperglycemia and Rash Management: Janie Metsker, RN

309

Informed Approach to Emotional Trauma for Cancer Patients: Elizabeth Archer-Nanda and Meagan Dwyer

310

Bolstering Leadership Skills in Oncology Nursing: Nick Escobedo, DNP, RN

311

Applying Nursing Civility in Oncology: Susan Rux, PhD

312

How to Empower Bedside Oncology Nurses as Leaders: Tammy Triglianos, DNP, ANP-BC, AOCNP

313

Staying Proficient in Managing Chronic Cancer-Related Pain: Tanya Uritsky, PharmD

314

Piloting Melanoma Research and Local Cancer Care With Richard Carvajal, MD

315

New and Exciting Directions in Leukemia Research: Fellows Forum With Sunil Iyer, MD

316

Fellows Forum: A Valuable Resource for Hematology/Oncology Fellows With Samuel Kareff, MD, MPH

317

ONS Live Podcast: Staying Proficient in Managing Chronic Cancer-Related Pain

318

Creating an Informed Approach to Mental and Emotional Trauma Experienced by Cancer Patients

319

Health Care Violence Trends And Prevention Strategies: Scott Christensen, DNP, MBA, APRN, ACNP-BC

320

Driving Health Care Accessibility Through Acute Myeloid Leukemia Research With Ian Bouligny, MD

321

Faculty Interview & Free CME/NCPD Activity: Chemotherapy-Induced Neutropenia

322

Advocating for Equitable Care in Multiple Myeloma: With Shakira Grant, MBBS

323

Incorporating Patient-Reported Outcomes Into Prostate Cancer Treatment With Lisa Gudenkauf, PhD

324

Do Accelerated Approvals Really Benefit Patients? With Ravi Parikh, MD, MPP

325

Rare Disease Day With Thomas Abrams, MD; Maria Badillo, RN, OCN®, CCRP; and Ulka Vaishampayan, MD

326

Additional Advances in NSCLC Research and Clinical Trials With Ticiana Leal, MD

327

Studying Olutasidenib in Relapsed/Refractory Acute Myeloid Leukemia With Jorge Cortes, MD

328

Describing Real-World Treatment Patterns for Myelodysplastic Syndromes With Ira Zackon, MD

329

Investigating Momelotinib for Treatment of Myelofibrosis With Srdan Verstovsek, MD, PhD

330

Additional Advances in Graft-Versus-Host Disease Research and Clinical Trials: Shernan Holtan, MD

331

Additional Advances in NSCLC Research and Clinical Trials With Beth Sandy, MSN, CRNP

332

Additional Advances in Immune Thrombocytopenia Research and Clinical Trials

333

Subsequent Treatment After CAR T-Cell Therapy in Large B-Cell Lymphoma With Armin Ghobadi, MD

334

Investigating Brentuximab Vedotin for Advanced-Stage Hodgkin Lymphoma With Habte Yimer, MD

335

Updates on Trials of Zilovertamab and Brentuximab Vedotin in Lymphomas With Hun Lee, MD

336

Improving the Standard of Care for Advanced Hodgkin Lymphoma With Mitul Gandhi, MD

337

Optimizing Patient Outcomes With CAR T-Cell Therapy With Ola Oluwole, MD

338

Association of Socioeconomic Status With Adherence and Survival in Myeloma: Leon Bernal-Mizrachi, MD

339

Advancing the Careers of Women in Hematology With Ariela Marshall, MD

340

Making Health Care Accessible for Acute Myeloid Leukemia Patients With Ian Bouligny, MD

341

Factors Leading to Black Patient Disparities in Hematology Trials With Shakira Grant, MBBS

342

Creating Valuable Education for the Hematology/Oncology Fellow: Ronak Mistry and Vivek Patel

343

Exploring the Results of Elranatamab for Relapsed/Refractory Multiple Myeloma With Noopur Raje, MD

344

Dynamic Risk Classification of Smoldering Myeloma With Luis Gerardo Rodríguez-Lobato, MD, PhD

345

Understanding Multiple Myeloma Treatment Patterns and Sequencing With Robert Rifkin, MD

346

Investigating CAR T Wait Time and High-Risk Myeloma Definitions With Samer Al Hadidi, MD, MS, FACP

347

Exploring Results of the SUNLIGHT Trial in Metastatic Colorectal Cancer: Josep Tabernero, MD, PhD

348

Investigating the Efficacy of HPN217 in Relapsed/Refractory Multiple Myeloma With Luke Walker, MD

349

Additional Advances in Chemotherapy-Induced Neutropenia Research and Clinical Trials

350

Multiple Myeloma Trials and Quality News Reporting With Manni Mohyuddin, MBBS

351

Discussing the Relevance of Urine Studies in Myeloma With Kelsey Natsuhara, MD

352

Studying the Promising Role of Bispecific Antibodies in Multiple Myeloma With Ajai Chari, MD

353

Additional Advances in Acute Leukemia Research and Clinical Trials: Amir Fathi, MD

354

Additional Advances in Squamous NSCLC Research and Clinical Trials With Mark Kris, MD

355

Pioneering the Field of Stem Cell Biology With Irving Weissman, MD

356

Additional Advances in Multiple Myeloma Research and Clinical Trials With Shaji Kumar, MD

357

Additional Advances in Multiple Myeloma Research and Clinical Trials: Sarah Holstein, MD, PhD

358

Highlights from the San Antonio Breast Cancer Symposium

359

CLL Society, a Valuable Resource for Patients and the Health Care Team: Brian Koffman, MD

360

Predicting Invasive Lobular Carcinoma Prognosis Through Absence of Lobular Carcinoma in Situ

361

Emphasizing Communication and Expectations for Lung Cancer Side Effects With Blanca Ledezma, MSN, NP

362

Personalizing Prostate Cancer Therapy With Christopher Iannuzzi, MD

363

Additional Advances in Waldenstrom Macroglobulinemia Research and Clinical Trials: Morie Gertz, MD

364

Additional Advances in Myelofibrosis Research and Clinical Trials With John Mascarenhas, MD

365

Understanding Clonal Hematopoiesis With Rahul Banerjee, Jeremy Meier, and Samuel Rubinstein

366

The Power of Metastatic Breast Cancer Retreats With Lillie Shockney and Janie Metsker

367

An Introduction to Breast Cancer Therapies: A Patient Resource From Samuel Kareff, MD, MPH

368

Raising Awareness for Breast Cancer Risks in Transgender Patients With Valerie Brutus, MD, FACS

369

Men Can Get Breast Cancer Too: Valerie Brutus, MD, FACS

370

Bringing Attention to Breast Cancer Reconstructive Surgery Options With Elizabeth Stirling Craig, MD

371

Breast Cancer Is Not Just One Disease: Lobular Breast Cancer Research With Jason Mouabbi, MD

372

Blood Cancer Awareness Month: Exploring Patient-Reported Outcomes: Rahul Banerjee and Ajay Major

373

Personalizing Lung Cancer Care Through Biomarkers and Precision Medicine: Blanca Ledezma, MSN, NP

374

Caring for Patients Receiving CAR T-Cell Therapy

375

Addressing Clinical Trial Accrual of Minority Patients With Donna Catamero, NP

376

Determining Patient Selection for CAR T-Cell Therapy in Multiple Myeloma With Beth Faiman, PhD, CNP

377

No One Left Alone: Taking the First Steps to Address Cancer Disparities With Kashyap Patel, MD

378

Guiding Breast Cancer Surgical Decisions With Valerie Brutus, MD, FACS

379

The Future of MRD in Multiple Myeloma Treatment Decision Making

380

Increasing Medical Student Confidence When Treating LGBTQIA+ Patients

381

Understanding the Current Landscape of Chemotherapy-Induced Neutropenia

382

World Lung Cancer Day With Beth Sandy, MSN, CRNP, and Corey Langer, MD

383

Tackling Violence and Stigmatization to Decrease Disparities for Transgender Patients: Ash Alpert

384

Discussing Patient-Reported Hope in Early Phase Clinical Trials With Debra Lundquist, PhD, RN

385

Neuroblastoma Risk Stratification and Research: Wendy London, PhD

386

HRAS Mutations in Breast Cancer: Sam Kareff, MD, MPH

387

Perspectives on the Most Exciting Research at ASCO: Navdeep Dehar, MD

388

A Patient's Perspective on Breast Cancer and Advocacy: Megan - Claire Chase

389

Medical Student Readiness to Treat LGBTQIA+ Patients: Matthew Schabath, PhD

390

Remote Symptom Monitoring and Management: Kathi Mooney, PhD, RN

391

Breast Cancer Prevention and Disparities: Jessica Jones, MD

392

The Nurse's Role in Oncology Research and Quality Care: Jeannine Brant, PhD, APRN

393

Lobular Breast Cancer Histology and Research: Jason Mouabbi, MD

394

Patritumab Deruxtecan for HER3-Expressing Metastatic Breast Cancer: Ian Krop, MD, PhD

395

Transforming Cancer Care Delivery and Patient Experiences Through Technology: David Penberthy, MD

396

Ocular Melanoma and Patient Advocacy: Danet Peterson

397

Ocular Oncology and the Personalized Approach: Dan Gombos, MD

398

Thriving Beyond the Cancer Diagnosis: Colin Ferro

399

Project Koru and Cancer Survivorship: Beth Peck

400

Pathology and Personalized Medicine: Aamir Ehsan, MD

401

Understanding Research on Novel Treatments and Nutritional Interventions for Myeloma: Urvi Shah, MD

402

Addressing Racial Disparities in Multiple Myeloma Treatment Outcomes

403

From the Patient’s Perspective: Improving Quality of Care for the LGBTQIA+ Community

404

Raising Awareness About Medical Aid in Dying With Janet Rowe and Lisa Vigil Schattinger

405

Improving Quality of Care for the LGBTQIA+ Cancer Community With Don Dizon

406

How to Build a Diverse Nursing Work Force With Maria Badillo and Diane Barber

407

The Ever-Changing Opportunities of Research Nursing

408

Nursing Considerations for CAR T-Cell Therapy With Maria Badillo and Sherry Adkins

409

Exploring the Impact of Cemiplimab and Pembrolizumab in Cutaneous Squamous Cell Carcinoma

410

Taking a Nuanced Approach to Testicular Cancer Management With Sam Kaffenberger, MD

411

Prioritizing Life After Testicular Cancer With Katie Murray, DO

412

Can Digital Health Tools Improve Quality of Life in Multiple Myeloma?

413

Exploring Recent Advances in Testicular Cancer Surgery and Access to Care

414

Personalizing the Approach to Testicular Cancer Management With Aditya Bagrodia, MD, FACS

415

Considering VTE Risk Factors and Prophylaxis in Myeloma: Rajshekhar Chakraborty and Rahul Banerjee

416

Can Diet and Nutrition Impact Multiple Myeloma Outcomes? Urvi Shah and Rahul Banerjee

417

The Groundbreaking Approval of Tebentafusp for Uveal Melanoma With Richard Carvajal, MD

418

Advocating for Patients in Multiple Myeloma Clinical Trials: Manni Mohyuddin and Rahul Banerjee

419

The Roles of Etiology and Biopsy in Hepatocellular Carcinoma With Augusto Villanueva, MD, PhD

420

Rare Disease Day With Amy DeZern, MD, MHS: Making Progress in Myelodysplastic Syndromes

421

World Cancer Day With Thomas Abrams, MD; Ulka Vaishampayan, MD; and Beth Sandy, MSN, CRNP

422

Can Digital Life Coaching Improve Quality of Life in Transplant? Rahul Banerjee and Kelly Brassil

423

Cabozantinib/Atezolizumab for Metastatic Colorectal Cancer: Thomas Abrams, MD

424

Targeting p53 in the Treatment of Hematologic Malignancies With Matthew Davids, MD, MMSc

425

The Call to Understand Racial Disparities in Pediatric Acute Lymphoblastic Leukemia: Sumit Gupta, MD

426

Applying Recent Advances to Personalized Breast Cancer Care: Brigid Killelea, MD, FACS

427

Making Strides in Breast Cancer Treatment With Richard Zelkowitz, MD

428

Insights Into Breast Cancer Treatment and Management in the COVID-19 Pandemic: Valerie Brutus, MD

429

Breast Cancer Awareness Month With Christine Samuel, Mikel Ross, and Lillie Shockney

430

How to Help Breast Cancer Survivors Become Breast Cancer Thrivers: Lillie Shockney, RN

431

Breast Cancer and Pandemic Challenges With Lillie Shockney, RN, BS, MAS, HON-ONN-CG

432

Overcoming Pandemic Challenges in Breast Cancer Care With Erin Prendergast, RN, CBCN®

433

Enhancing Quality of Life in Breast Cancer With Lillie Shockney, RN, BS, MAS

434

Understanding Breast Cancer Surgery and Reconstruction: Lillie S. Shockney, RN, BS, MAS, HON-ONN-CG

435

Developments in Breast Imaging and Radiology: A Conversation With Tricia Trammell

436

Patients Need Layers of Support: Oncology Nurse Navigation With Judy Herrick, RN, OCN®, ONN-CG

437

Breast Cancer Pathology and Setting the Stage for Treatment: Lillie Shockney, RN, HON-ONN-CG

438

Importance of 3D Mammogram Screening by Breast Imaging Radiologists With Lillie S. Shockney, RN

439

Perspectives on Metastatic and Castration-Resistant Prostate Cancer With Ulka Vaishampayan, MD

440

Breast Cancer Genetic Risk and Evaluation With Lillie S. Shockney, RN, BS, MAS, HON-ONN-CG

441

Breast Cancer Risk Factors and Prevention With Lillie S. Shockney, RN, BS, MAS, HON-ONN-CG

442

Optimizing Treatment of Immune Thrombocytopenia: A Conversation With Allison Imahiyerobo, APN

443

Recent Advances in the Treatment of T-Cell Lymphoma: A Conversation With Dr. Steven Horwitz

444

Improving the Management of Metastatic Breast Cancer: A Conversation With Dr. Sara Tolaney